As of Oct 21
| -0.16 / -0.29%|
The 4 analysts offering 12-month price forecasts for Magellan Health Inc have a median target of 64.00, with a high estimate of 76.00 and a low estimate of 55.00. The median estimate represents a +15.77% increase from the last price of 55.28.
The current consensus among 6 polled investment analysts is to Hold stock in Magellan Health Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.